--2025/Q1-- / 13.200M--
--2024/Q4-- / 15.122M--
Nov 5, 20242024/Q314.269M / 14.132M--
--2024/Q211.772M / 13.047M--
--2024/Q17.410M / 14.664M--
US Stock MarketDetailed Quotes
BEAM Beam Therapeutics
- 26.650
- +1.600+6.39%
Close Nov 25 16:00 ET
- 26.650
- 0.0000.00%
Post 16:47 ET
2.21BMarket Cap-16867P/E (TTM)
26.900High25.590Low1.22MVolume25.940Open25.050Pre Close32.18MTurnover1.77%Turnover RatioLossP/E (Static)82.81MShares49.50052wk High2.79P/B1.83BFloat Cap20.84052wk Low--Dividend TTM68.63MShs Float138.522Historical High--Div YieldTTM5.23%Amplitude13.000Historical Low26.434Avg Price1Lot Size
Beam Therapeutics Key Stats
Beam Therapeutics Q3 2024 Earnings Date
Currency：USDNov 5, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 14.13M | 14.27M | +137.03K |
| Beat Est. | -17.80% | -17.01% | +0.97% |
| EPS | -1.15 | -1.17 | -0.02 |
| Miss Est. | +6.12% | +4.10% | -2.17% |
Analyst Rating
Nov 6, 2024
Beam Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Beam Therapeutics Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
